Interferon-β attenuates lung inflammation following experimental subarachnoid hemorrhage

Critical Care

Volumn 14, Issue 4, 2010, Pages

  Cobelens, Pieter M ^a   Tiebosch, Ivo A C W ^b   Dijkhuizen, Rick M ^b   van der Meide, Peter H ^c   Zwartbol, René ^b   Heijnen, Cobi J ^a   Kesecioglu, Jozef ^a   van den Bergh, Walter M ^a,d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; CXCL1 CHEMOKINE; CXCL1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; LUNG INJURY; MALE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SUBARACHNOID HEMORRHAGE; ACUTE LUNG INJURY; ANIMAL; CHEMISTRY; DRUG EFFECT; INFLAMMATION; LUNG; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WISTAR RAT;

ACUTE LUNG INJURY; ANIMALS; CHEMOKINE CCL3; CHEMOKINE CXCL1; E-SELECTIN; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-BETA; LUNG; MALE; NEUTROPHIL INFILTRATION; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUBARACHNOID HEMORRHAGE; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 77955816691     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9232     Document Type: Article

References (25)

1. Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 2009, 8:635-642. 10.1016/S1474-4422(09)70126-7, 19501022.
2. Wartenberg KE, Schmidt JM, Claassen J, Temes RE, Frontera JA, Ostapkovich N, Parra A, Connolly ES, Mayer SA. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med 2006, 34:617-623. 10.1097/00003246-200612002-00426, 16521258.
3. Kahn JM, Caldwell EC, Deem S, Newell DW, Heckbert SR, Rubenfeld GD. Acute lung injury in patients with subarachnoid hemorrhage: incidence, risk factors, and outcome. Crit Care Med 2006, 34:196-202. 10.1097/01.CCM.0000194540.44020.8E, 16374174.
4. Solenski NJ, Haley EC, Kassell NF, Kongable G, Germanson T, Truskowski L, Torner JC. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med 1995, 23:1007-1017. 10.1097/00003246-199506000-00004, 7774210.
5. Gruber A, Reinprecht A, Illievich UM, Fitzgerald R, Dietrich W, Czech T, Richling B. Extracerebral organ dysfunction and neurologic outcome after aneurysmal subarachnoid hemorrhage. Crit Care Med 1999, 27:505-514. 10.1097/00003246-199903000-00026, 10199529.
6. Muroi C, Keller M, Pangalu A, Fortunati M, Yonekawa Y, Keller E. Neurogenic pulmonary edema in patients with subarachnoid hemorrhage. J Neurosurg Anesthesiol 2008, 20:188-192. 10.1097/ANA.0b013e3181778156, 18580349.
7. Theodore J, Robin ED. Pathogenesis of neurogenic pulmonary oedema. Lancet 1975, 2:749-751. 10.1016/S0140-6736(75)90729-1, 52777.
8. Lucas SM, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol 2006, 147(Suppl 1):S232-S240. 10.1038/sj.bjp.0706400, 1760754, 16402109.
9. Mascia L. Acute lung injury in patients with severe brain injury: a double hit model. Neurocrit Care 2009,
10. Dreyfuss D, Saumon G. Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med 1998, 157:294-323.
11. Josephson SA, Douglas VC, Lawton MT, English JD, Smith WS, Ko NU. Improvement in intensive care unit outcomes in patients with subarachnoid hemorrhage after initiation of neurointensivist co-management. J Neurosurg 2010, 112:626-630. 10.3171/2009.8.JNS09441, 19731990.
12. Billiau A, Kieseier BC, Hartung HP. Biologic role of interferon beta in multiple sclerosis. J Neurol 2004, 251(Suppl 2):II10-14.
13. Veldhuis WB, Derksen JW, Floris S, van der Meide PH, De Vries HE, Schepers J, Vos IM, Dijkstra CD, Kappelle LJ, Nicolay K, Bar PR. Interferon-beta blocks infiltration of inflammatory cells and reduces infarct volume after ischemic stroke in the rat. J Cereb Blood Flow Metab 2003, 23:1029-1039. 10.1097/01.WCB.0000080703.47016.B6, 12973019.
14. Cobelens PM, van Putte BP, Kavelaars A, Heijnen CJ, Kesecioglu J. Inflammatory consequences of lung ischemia-reperfusion injury and low-pressure ventilation. J Surg Res 2009, 153:295-301. 10.1016/j.jss.2008.04.022, 18952232.
15. Lee JY, Sagher O, Keep R, Hua Y, Xi G. Comparison of experimental rat models of early brain injury after subarachnoid hemorrhage. Neurosurgery 2009, 65:331-343. 10.1227/01.NEU.0000345649.78556.26, 19625913.
16. Prunell GF, Mathiesen T, Svendgaard NA. Experimental subarachnoid hemorrhage: cerebral blood flow and brain metabolism during the acute phase in three different models in the rat. Neurosurgery 2004, 54:426-436. 10.1227/01.NEU.0000103670.09687.7A, 14744290.
17. Thal SC, Mebmer K, Schmid-Elsaesser R, Zausinger S. Neurological impairment in rats after subarachnoid hemorrhage--a comparison of functional tests. J Neurol Sci 2008, 268:150-159. 10.1016/j.jns.2007.12.002, 18191151.
18. Wagner JG, Roth RA. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol Rev 2000, 52:349-374.
19. Spengler RN, Allen RM, Remick DG, Strieter RM, Kunkel SL. Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J Immunol 1990, 145:1430-1434.
20. Flierl MA, Rittirsch D, Nadeau BA, Sarma JV, Day DE, Lentsch AB, Huber-Lang MS, Ward PA. Upregulation of phagocyte-derived catecholamines augments the acute inflammatory response. PLoS One 2009, 4:e4414. 10.1371/journal.pone.0004414, 2636885, 19212441.
21. Shahangian A, Chow EK, Tian X, Kang JR, Ghaffari A, Liu SY, Belperio JA, Cheng G, Deng JC. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest 2009, 119:1910-1920. 10.1172/JCI35412, 2701856, 19487810.
22. Ferriby D, Stojkovic T. Clinical picture: bronchiolitis obliterans with organising pneumonia during interferon beta-1a treatment. Lancet 2001, 357:751. 10.1016/S0140-6736(00)04167-2, 11253968.
23. Zang YC, Halder JB, Samanta AK, Hong J, Rivera VM, Zhang JZ. Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta. J Neuroimmunol 2001, 112:174-180. 10.1016/S0165-5728(00)00397-0, 11108946.
24. Floris S, Ruuls SR, Wierinckx A, van der Pol SM, Dopp E, van der Meide PH, Dijkstra CD, De Vries HE. Interferon-beta directly influences monocyte infiltration into the central nervous system. J Neuroimmunol 2002, 127:69-79. 10.1016/S0165-5728(02)00098-X, 12044977.
25. Kiss J, Yegutkin GG, Koskinen K, Savunen T, Jalkanen S, Salmi M. IFN-beta protects from vascular leakage via up-regulation of CD73. Eur J Immunol 2007, 37:3334-3338. 10.1002/eji.200737793, 18034430.